At a glance
- Originator Janssen L.P.
- Class Antiretrovirals
- Mechanism of Action RNA-directed DNA polymerase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
Most Recent Events
- 21 Mar 1995 No-Development-Reported for HIV infections treatment in Belgium (PO)
- 21 Mar 1995 No-Development-Reported for HIV infections treatment in France (PO)
- 21 Mar 1995 No-Development-Reported for HIV infections treatment in United Kingdom (PO)